Chronic active BCR signaling is typical of ABC (activated B cell) DLBCL, the subgroup of DLBCL with constitutive activation of NFκB (nuclear factor κB), also regulated by PI3K [53]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.